SKYRIZI® (risankizumab), an IL-23 inhibitor, received two consecutive positive reimbursement recommendations by Canada’s Drug ...
Engineered T cells that have been used to treat ulcerative colitis, rheumatoid arthritis and lupus show promising results.
The first week of December marks Crohn's & Colitis Awareness Week. Since 1990, cases of inflammatory bowel disease (IBD) have ...
AbbVie Scores Canadian Reimbursement Recommendations For Blockbuster Ulcerative Colitis Drug Skyrizi
AbbVie secures Canadian support for Skyrizi in ulcerative colitis with new reimbursement recommendations and a completed pCPA agreement.
Ulcerative colitis (UC) is one of the most common inflammatory bowel diseases, a lifelong condition that can cause chronic ...
News-Medical.Net on MSN
Toxin-secreting gut bacterium emerges as a driver of ulcerative colitis
A toxin-secreting gut bacterium may fuel ulcerative colitis by killing protective immune cells that maintain intestinal ...
Here are some tips to manage irritable bowel disease (IBD) and protect your stomach during the holidays and beyond.
A gut microbe secretes macrophage-targeting factors, rendering the intestinal layer vulnerable to ulcerative colitis, ...
A variant of the Aeromonas bacterium promoted colon inflammation in mice and was detected in stools and colon tissue from ...
Everyday Health on MSN
5 Ulcerative Colitis–Friendly Alternatives to Sugar
Find out why UC-friendly sweeteners like honey, maple syrup, and monk fruit are better for gut health than refined sugars.
Surgery can often cure long-term ulcerative colitis (UC), but it's not for everyone. Your doctor may suggest an operation if your UC is severe and you don't get enough help from other treatments, like ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results